Makes sucralose sweetener through a specialized chemical process and sells it to consumers and food companies under the Splenda brand.
At a glance
- Depends onDownstream position: depends on 8 industries, supplies 5
- Scale
Makes sucralose sweetener through a specialized chemical process and sells it to consumers and food companies under the Splenda brand.
Latest report · July 8, 2026
Read the full structural reportWhat this company is and how it runs — written from structure, not news.
Tate & Lyle converts corn starch into sucralose — a sweetener made by chlorinating sugar molecules — and sells it under the Splenda brand, which means a food manufacturer buying from Tate & Lyle is locked into both the ingredient and the retail identity at the same time. Because sucralose's heat-stability and sweetness intensity come from the chlorination step itself, any manufacturer who builds a diet beverage or baked good around those properties would need FDA re-approval, new retailer shelf agreements, and fresh consumer taste-testing to switch to anything else. The chlorination facilities that make this possible — four sites in Alabama, China, Singapore, and Mexico — each required specialized chemical infrastructure and a multi-year food-grade regulatory approval cycle to certify, so new supply cannot be built quickly even if the capital is there. The whole structure rests on the FDA's existing safety designation for sucralose: if regulators tighten acceptable daily intake limits or suspend that approval, the production facilities lose their food-grade standing and the Splenda brand loses its safety story at exactly the same moment.
How does this company make money?
The company earns money in three ways. It sells sucralose in bulk, by the kilogram, directly to food and beverage manufacturers. It sells packaged Splenda products by the unit through retail grocery stores. And it collects licensing fees from strategic partners who manufacture their own products using the Splenda brand name.
What makes this company hard to replace?
A food or beverage company that wants to replace sucralose with a different sweetener must first get FDA re-approval for the reformulated product — that process takes time and money regardless of what the replacement is. It must also renegotiate retailer shelf agreements that were set up around the Splenda name, and run consumer taste-testing cycles because sucralose has a specific sweetness intensity that other sweeteners do not match exactly. Production lines calibrated for sucralose may also need physical adjustment to handle a different ingredient.
What limits this company?
Building a new sucralose factory is not just an engineering problem — it requires environmental permits for chlorinated chemical manufacturing and a multi-year government approval process to certify it for food production. No amount of money speeds that up. That approval timeline is the hard ceiling on how quickly supply can grow, whether demand rises or an existing factory runs into trouble.
What does this company depend on?
The company cannot run without corn starch from U.S. and international suppliers, which is the raw material that sucralose is made from. It also depends on chlorination chemistry licensing from the original sucralose patents, FDA GRAS approval and equivalent food safety certifications in every country where it operates, specialized chemical processing equipment built for selective chlorination, and maltodextrin and other bulking agents used to make the consumer products.
Who depends on this company?
Coca-Cola and PepsiCo beverage teams depend on proven sucralose blends for their diet drink formulations — losing access would force them through expensive reformulation and re-approval. Industrial bakeries rely on Splenda's heat-stability for reduced-sugar baked goods, a property that most alternative sweeteners do not match. Manufacturers of diabetic and weight-management foods depend on consistent sucralose supply to keep making products with government-approved low-calorie claims.
How does this company scale?
Blending sucralose into finished consumer products and packaging it can be expanded relatively easily using standard food processing equipment and existing distribution networks. The bottleneck that never goes away is the chlorination step itself — every new production facility still needs specialized chemical infrastructure, environmental permits, and a multi-year regulatory approval cycle, no matter how large the company grows.
What external forces can significantly affect this company?
The biggest external threat is the FDA or international food safety agencies tightening acceptable daily intake limits for artificial sweeteners or requiring new safety studies that put existing approvals on hold. Corn commodity prices — which move with U.S. ethanol mandate policies — directly affect the cost of the starch inputs used to make sucralose. Chinese environmental regulations restricting chemical manufacturing could limit production at the facility operating there.
Where is this company structurally vulnerable?
If the FDA — or equivalent regulators in other countries — tightened the acceptable daily intake for sucralose, or suspended the existing GRAS safety designation to require new studies, the damage would hit both sides at once. The factories would lose their food-grade certification, and the Splenda brand would lose the safety story that justifies its place on store shelves. One regulatory decision would knock out both the production side and the consumer-facing side in the same moment.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign in1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock behaving?
Current close sits in the upper portion of the 14-week high-low range; current close sits in the upper portion of its 20-week Bollinger Bands; RSI sits above its 20-week recent mean (Bollinger %B applied to RSI).
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Three observations have aligned in the down direction: the share of down-close weeks within the one-year lookback is high, the earnings-compression observation scores high, and the gross-profit-deterioration observation scores high.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
Tate & Lyle Public Limited Company
July 8, 2026 · CompanyGraph · TATE
Tate & Lyle reported positive net income in every fiscal year from FY2021 through FY2025, and across those years taxes and interest together took only a small share of operating profit (as of the March 2025 statements). CompanyGraph reads its structure as bending the usual branded-food pattern: the Splenda brand looks fused to a specific molecule and its safety approval, which — if true — would concentrate its exposure in regulation rather than taste. That fusion is a reading, not a confirmed fact, and the held data carries no segment breakdown to test how large that sweetener line actually is.
Read the full reportFollow cattle from feed and biological growth through transport, slaughter, carcass balance, processing, cold storage, cooking, and recovery. One animal becomes many outputs while grinding merges many identities, so time, traceability, welfare, and money determine usable food.
Follow cacao from tree and pod through harvest, fermentation, drying, aggregation, factory separation, chocolate manufacture, use, and residuals. The bean is not the constant object: each stage creates a new condition and closes earlier options.
Coffee can reach the cup even when much of its history has disappeared. Follow the chain to see what gets damaged, what money makes possible, what records can prove, and where responsibility breaks.
Follow food from biological ingredients through formulation, preservation, packaging, distribution, and consumption. The chain carries nutrition and culinary function, but each processing step creates conditions, losses, waste, and records that only partly describe what a person finally eats.
Follow wild or farmed seafood through harvest, chilling, processing, sale, consumption, and residuals. Biological renewal before harvest and irreversible quality loss after it make quotas, ice, payment, identity, and feedback part of the food supply.
Follow sucrose from a living cane stalk or beet root into a uniform crystal, then through food, fermentation, and residues—and see what concentration makes possible and what it disconnects.
CompanyGraph